Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Somya Ranjan Dash"'
Autor:
Chanakya Nath Kundu, Somya Ranjan Dash
Publikováno v:
Current Pharmaceutical Biotechnology. 24:1365-1375
Abstract: Cancer patients frequently report experiencing pain as one of their symptoms. Cancerrelated pain is often caused by the tumor itself, especially when the tumor is pressing on nerves. In addition to the pain caused by the tumor itself, patie
Autor:
Somya Ranjan Dash, Chanakya Nath Kundu
Publikováno v:
Biomaterials Science. 11:3431-3449
An efficient anti-viral therapy strategy based on nanomedicine.
Autor:
Somya Ranjan Dash, Biswajit Das, Chinmay Das, Saptarshi Sinha, Subarno Paul, Rajalaxmi Pradhan, Chanakya Nath Kundu
Publikováno v:
Nanomedicine. 18:19-33
Aim: This study aimed to explore the antiangiogenic mechanism of quinacrine-gold hybrid nanoparticle (QAuNP) and near-infrared (NIR) radiation in patient-derived primary breast cancer stem cells. Materials & methods: Various cell-based in ovo angioge
Autor:
Biswajit Das, Chinmayee Sethy, Subhajit Chatterjee, Somya Ranjan Dash, Saptarshi Sinha, Subarno Paul, Kunal Goutam, Chanakya Nath Kundu
Publikováno v:
Journal of Cell Communication and Signaling.
A trans-membrane receptor, mesenchymal-epithelial transition factor (cMET), is responsible for cancer metastasis and angiogenesis. A very little is known about the role of cMET in cancer stem cells (CSCs). Quinacrine (QC), a bioactive agent, has show
Autor:
Chanakya Nath Kundu, Somya Ranjan Dash
Publikováno v:
Current Nanoscience. 18:31-47
The use of hyperthermal temperature to treat solid cancers is known as oncological thermal ablation. Thermal ablation is studied as a therapeutic strategy for most cancers and can be used in the control of local and metastatic diseases in addition to
Autor:
Saptarshi Sinha, Subhajit Chatterjee, Subarno Paul, Biswajit Das, Somya Ranjan Dash, Chinmay Das, Chanakya Nath Kundu
Publikováno v:
Experimental cell research. 420(1)
Although sensitization of BRCA-mutated, homologous recombination (HR)-deficient breast cancer cells through PARP inhibitor is widely studied, not much is known about the treatment of BRCA-wild-type, HR-proficient breast cancer. Here, we aim to invest
Autor:
Chanakya Nath Kundu, Somya Ranjan Dash, Jasaswini Tripathy, Smith Sagar Satapathy, Rupayana Panda
Publikováno v:
Materials Today: Proceedings. 47:1193-1196
Gold nanorods (GNR) are considered as potential candidates for varied biological applications. They are synthesized using the cationic surfactant layers such as cetyltrimethylammonium bromide (CTAB), which create the limitation towards biocompatibili
Autor:
Biswajit Das, Chinmayee Sethy, Krushna Chandra Hembram, Chanakya Nath Kundu, Birendra Kumar Bindhani, Subhajit Chatterjee, Somya Ranjan Dash
Publikováno v:
Molecular Pharmaceutics. 17:2463-2472
The presence of cancer stem cells (CSCs) in the tumor microenvironment is responsible for the development of chemoresistance and recurrence of cancer. Our previous investigation revealed the anticancer mechanism of quinacrine-based silver and gold hy
Autor:
Rajalaxmi Pradhan, Subarno Paul, Biswajit Das, Saptarshi Sinha, Somya Ranjan Dash, Mahitosh Mandal, Chanakya Nath Kundu
Publikováno v:
The Journal of Nutritional Biochemistry. 113:109257
Cancer associated fibroblasts (CAFs) are one of the highly abundant components in the tumor microenvironment (TME). They secrete several cytokines, which amplified tumor progression, invasion, stemness, metastasis and angiogenesis. Here, we evaluate
Autor:
Subhajit Chatterjee, Ajit Kumar Dhal, Subarno Paul, Saptarshi Sinha, Biswajit Das, Somya Ranjan Dash, Chanakya Nath Kundu
Publikováno v:
Journal of cancer research and clinical oncology. 148(12)
Inhibition of Poly (ADP-ribose) Polymerases (PARP) results in the blocking of DNA repair cascades that eventually leads to apoptosis and cancer cell death. PARP inhibitors (PARPi) exhibit their actions either by inhibiting PARP-induced PARylation and